Biotech Startups
9,990 companies tagged Biotech, with their investors and founders.
0 investors
Auxergen is an agricultural biotechnology R&D company developing biological treatments such as CitriPhage for citrus canker, bio-treatments for Olive Quick Decline Syndrome, and bioremediation and phage-based technologies. It operates within the University of Maryland incubator system and serves agriculture, human health, and environmental sustainability markets, with international operations including a subsidiary in Bari, Italy.
0 investors
Auxilium Biotechnologies develops regenerative medicine devices, including the NeuroSpan Bridge, an implantable device to aid peripheral nerve regeneration. The company also works on in-space biomanufacturing, having demonstrated 3D bioprinting of implantable medical devices in microgravity aboard the ISS.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Avenacy develops and supplies sterile injectable medications for pharmacists and patients, with packaging and labeling designed to reduce administration errors and dosing mistakes. It operates in the pharmaceutical industry with a focus on injectable drug products.
0 investors
0 investors
Avenzoar Pharmaceuticals is a pharmaceutical company developing therapies through its team of scientists and researchers. The page provides team information but limited detail on specific products or focus areas.
0 investors
Aveta Biomics develops cancer therapeutics based on Orthologous Molecular Structures (OMS), metabolites from organisms with orthologous genes and processes, combined using an evolutionary-biology-based platform. Its drugs aim to treat and prevent cancers while addressing tumor heterogeneity and drug resistance.
0 investors
BioCentury provides news, analysis, and data covering the biotechnology and pharmaceutical industries.
0 investors
0 investors
0 investors
RECELL is an FDA-approved autologous skin cell suspension device for treating burns, trauma, and surgical wounds by harvesting a patient's own skin cells and applying them to accelerate healing and reduce the need for large skin grafts. The technology serves hospital systems and wound care clinicians treating severe burn and trauma patients.
0 investors
0 investors
AVM Biotechnology develops AVM0703, a proprietary concentrated dexamethasone formulation designed to trigger the release and production of specialized immune cells (gamma delta and invariant TCR+ bispecific T lymphocytes and NK T-like cells) as a treatment approach for various diseases. The company operates in the biotechnology and immunotherapy space, with a therapeutic candidate in pre-clinical and clinical stages.
0 investors
0 investors
Axcend builds compact, portable HPLC (high-performance liquid chromatography) instruments, including the Focus LC line with automated sampling, real-time reaction monitoring, and multi-wavelength UV detection. Its analytical chemistry systems serve pharmaceutical, chemical, and educational customers for lab and production-line analysis.
0 investors
0 investors
0 investors
0 investors